Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-05-20

FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

The FDA approved a supplemental application to add the intravenous formulation of PROTONIX (pantoprazole sodium) from Wyeth Pharmaceuticals (a Pfizer subsidiary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROTONIX I.V. (pantoprazole sodium)

Snippet

SUPPL AP for PROTONIX I.V. (PANTOPRAZOLE SODIUM)